AChR Alpha5 Polyclonal Antibody

Cholinergic receptor nicotinic alpha 5 subunit encoded by CHRNA5 is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).

The ACHR ALPHA5 Polyclonal Antibody is a highly specialized and meticulously crafted product designed to cater to the needs of researchers and scientists in the field of neurobiology. This antibody is specifically developed to target and detect the alpha5 subunit of the acetylcholine receptor (ACHR), a crucial component in the transmission of nerve impulses.

With its exceptional specificity and sensitivity, the ACHR ALPHA5 Polyclonal Antibody offers an invaluable tool for investigating the intricate mechanisms underlying neuronal communication. Its polyclonal nature ensures a broad range of epitope recognition, enabling comprehensive analysis of ACHR alpha5 subunit expression across various experimental models and tissues.

This antibody is meticulously manufactured using state-of-the-art techniques and quality-controlled processes to ensure optimal performance and reproducibility. Rigorous testing and validation procedures guarantee the reliability and accuracy of results obtained with the ACHR ALPHA5 Polyclonal Antibody.

The ACHR ALPHA5 Polyclonal Antibody is supplied in a convenient and user-friendly format, allowing for easy integration into existing laboratory protocols. Its exceptional stability and long shelf life ensure consistent and reliable performance, making it an ideal choice for long-term studies and experiments.

In summary, the ACHR ALPHA5 Polyclonal Antibody is an indispensable tool for researchers and scientists seeking to unravel the complexities of neuronal communication. Its exceptional specificity, sensitivity, and reliability make it an invaluable asset in the pursuit of groundbreaking discoveries in the field of neurobiology.